Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2307
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients ; volume:452 ; number:6 ; day:20 ; month:3 ; year:2008 ; pages:651-665 ; date:6.2008
Virchows Archiv ; 452, Heft 6 (20.3.2008), 651-665, 6.2008
- Urheber
-
Keslová-Veselíková, Jana
Hůlková, Helena
Dobrovolný, Robert
Asfaw, Befekadu
Poupětová, Helena
Berná, Linda
Sikora, Jakub
Goláň, Lubor
Ledvinová, Jana
Elleder, Milan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00428-008-0586-9
- URN
-
urn:nbn:de:101:1-2021080707082260771737
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Keslová-Veselíková, Jana
- Hůlková, Helena
- Dobrovolný, Robert
- Asfaw, Befekadu
- Poupětová, Helena
- Berná, Linda
- Sikora, Jakub
- Goláň, Lubor
- Ledvinová, Jana
- Elleder, Milan
- SpringerLink (Online service)
Ähnliche Objekte (12)
![β-galactosidase [beta-galactosidase] production in two- and threedimensionally cultivated cell cultures](/assets/placeholder/searchResultMediaUnknown.png)
β-galactosidase [beta-galactosidase] production in two- and threedimensionally cultivated cell cultures
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
β-galactosidase [beta-galactosidase] activity in transfected Ltk- cells is differentially regulated in monolayer and in spheroid cultures
![Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]
Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
Bioengineered Gastrointestinal Tissues with Fibroblast‐Induced Shapes
Lysosomale β-Galactosidase [Beta-Galactosidase] der Rattenleber
Pirfenidone affects human cardiac fibroblast proliferation and cell cycle activity in 2D cultures and engineered connective tissues
Fabry-Münster-Studie (FaMüS) : Diskussion des Fabryzentrum-Münster-Kollektivs und der kardiologischen Effektivität der α-Galactosidase-Ersatz-Therapie [Alpha-Galactosidase-Ersatz-Therapie]
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease
β-galactosidase [beta-galactosidase] production in two- and threedimensionally cultivated cell cultures
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
β-galactosidase [beta-galactosidase] activity in transfected Ltk- cells is differentially regulated in monolayer and in spheroid cultures
Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]
Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
Bioengineered Gastrointestinal Tissues with Fibroblast‐Induced Shapes
Lysosomale β-Galactosidase [Beta-Galactosidase] der Rattenleber
Pirfenidone affects human cardiac fibroblast proliferation and cell cycle activity in 2D cultures and engineered connective tissues
Fabry-Münster-Studie (FaMüS) : Diskussion des Fabryzentrum-Münster-Kollektivs und der kardiologischen Effektivität der α-Galactosidase-Ersatz-Therapie [Alpha-Galactosidase-Ersatz-Therapie]
Affective and cognitive behavior in the alpha-galactosidase A deficient mouse model of Fabry disease
β-galactosidase [beta-galactosidase] production in two- and threedimensionally cultivated cell cultures
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Rats deficient in α-galactosidase A develop ocular manifestations of Fabry disease
β-galactosidase [beta-galactosidase] activity in transfected Ltk- cells is differentially regulated in monolayer and in spheroid cultures
Hydrophob immobilisierte β-Galactosidase [Beta-Galactosidase]
Characterisation of novel α-galactosidase [alpha-galactosidase] A mutations in Fabry disease based on in vitro, in vivo and pharmacological data
Bioengineered Gastrointestinal Tissues with Fibroblast‐Induced Shapes
Lysosomale β-Galactosidase [Beta-Galactosidase] der Rattenleber
Pirfenidone affects human cardiac fibroblast proliferation and cell cycle activity in 2D cultures and engineered connective tissues
Fabry-Münster-Studie (FaMüS) : Diskussion des Fabryzentrum-Münster-Kollektivs und der kardiologischen Effektivität der α-Galactosidase-Ersatz-Therapie [Alpha-Galactosidase-Ersatz-Therapie]